Cardiovascular effects: Phase 2 trial data indicate that retatrutide was associated with modest increases in resting heart rate, consistent with observations seen with other GLP-1 receptor agonists
This regenerative peptide is shown to promote angiogenesis, cellular repair, tissue growth, and improved inflammatory response [1, 2, 3]
Int J Obes Relat Metab Disord 25 (Suppl 5): S63S67 Horvath TL (2005) The hardship of obesity: a soft-wired hypothalamus
The frequency of these mononuclear cell aggregates may be exacerbated by treatment
Those with a personal or family history of thyroid cancer or thyroid tumors
Whilst gastrointestinal side effects are most common, skin reactions including injection site reactions and rashes can occur